(Q40250421)

18 September 2017

Evaluation of adenovirus vectors containing serotype 35 fibers for tumor targeting (English)

1 reference

18 September 2017

1 reference

Ni S

1

1 reference

18 September 2017

Gaggar A

2

1 reference

18 September 2017

Di Paolo N

3

1 reference

18 September 2017

Li ZY

4

1 reference

18 September 2017

Liu Y

5

1 reference

18 September 2017

Strauss R

6

1 reference

18 September 2017

Sova P

7

1 reference

18 September 2017

Morihara J

8

1 reference

18 September 2017

Feng Q

9

1 reference

18 September 2017

Kiviat N

10

1 reference

18 September 2017

Touré P

11

1 reference

18 September 2017

Sow PS

12

1 reference

18 September 2017

Lieber A

13

1 reference

18 September 2017

28 July 2006

1 reference

18 September 2017

1 reference

18 September 2017

13

1 reference

18 September 2017

1072-1081

1 reference

18 September 2017

12

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7700981

18 September 2017

0 references

cites work

What does it take to bind CAR?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700981

Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700981

Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700981

CD46 is a cellular receptor for group B adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700981

There are two different species B adenovirus receptors: sBAR, common to species B1 and B2 adenoviruses, and sB2AR, exclusively used by species B2 adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700981

Adenovirus type 11 uses CD46 as a cellular receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700981

Expression of membrane cofactor protein (MCP, CD46) in human liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700981

Obstacles to cancer immunotherapy: expression of membrane complement regulatory proteins (mCRPs) in tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700981

The innate immune response to adenovirus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700981

Impact of preimmunization on adenoviral vector expression and toxicity in a subcutaneous mouse cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700981

Development of an adenoviral vector system with adenovirus serotype 35 tropism; efficient transient gene transfer into primary malignant hematopoietic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700981

A tumor-targeted and conditionally replicating oncolytic adenovirus vector expressing TRAIL for treatment of liver metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700981

Analysis of adenovirus sequestration in the liver, transduction of hepatic cells, and innate toxicity after injection of fiber-modified vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700981

Evaluation of biodistribution and safety of adenovirus vectors containing group B fibers after intravenous injection into baboons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700981

Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700981

An adenoviral type 5 vector carrying a type 35 fiber as a vaccine vehicle: DC targeting, cross neutralization, and immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700981

Adenovirus types 5 and 35 seroprevalence in AIDS risk groups supports type 35 as a vaccine vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700981

Characterization of in vitro and in vivo gene transfer properties of adenovirus serotype 35 vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700981

Development of adenovirus serotype 35 as a gene transfer vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700981

A new type of adenovirus vector that utilizes homologous recombination to achieve tumor-specific replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700981

Bisulfite genomic sequencing: systematic investigation of critical experimental parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700981

The interaction between the fiber knob domain and the cellular attachment receptor determines the intracellular trafficking route of adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700981

Steps toward mapping the human vasculature by phage display.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700981

Disruption of 3D tissue integrity facilitates adenovirus infection by deregulating the coxsackievirus and adenovirus receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700981

Interference with the IL-1-signaling pathway improves the toxicity profile of systemically applied adenovirus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700981

High CD46 receptor density determines preferential killing of tumor cells by oncolytic measles virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700981

Icodextrin: a review of its use in peritoneal dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700981

Development of a formulation that enhances gene expression and efficacy following intraperitoneal administration in rabbits and mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700981

Complement inhibitor membrane cofactor protein (MCP; CD46) is constitutively shed from cancer cell membranes in vesicles and converted by a metalloproteinase to a functionally active soluble form

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700981

Development and assessment of human adenovirus type 11 as a gene transfer vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700981

Effect of adenovirus-mediated heat shock protein expression and oncolysis in combination with low-dose cyclophosphamide treatment on antitumor immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700981

Assessment of a combined, adenovirus-mediated oncolytic and immunostimulatory tumor therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700981

The influence of adenovirus fiber structure and function on vector development for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700981

Adenovirus Binding to Blood Factors Results in Liver Cell Infection and Hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700981

Efficient infection of tumor endothelial cells by a capsid-modified adenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700981

Discovery of novel methylation biomarkers in cervical carcinoma by global demethylation and microarray analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700981

Expression of complement regulatory proteins-CD 35, CD 46, CD 55, and CD 59-in benign and malignant endometrial tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700981

7 January 2021

Linking innate and acquired immunity: divergent role of CD46 cytoplasmic domains in T cell induced inflammation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700981

7 January 2021

Cell entry by measles virus: long hybrid receptors uncouple binding from membrane fusion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700981

7 January 2021

An adenoviral expression system for AAV rep78 using homologous recombination

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700981

7 January 2021

Method for multiple portal vein infusions in mice: quantitation of adenovirus-mediated hepatic gene transfer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700981

7 January 2021

Purification and functional properties of soluble forms of membrane cofactor protein (CD46) of complement: identification of forms increased in cancer patients' sera

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700981

7 January 2021

Identifiers

DOI

10.1038/SJ.CGT.7700981

1 reference

Dimensions Publication ID

18 September 2017

0 references

1 reference